JUL 17, 2015 11:12 PM PDT

Metabolism and Metastasis

WRITTEN BY: Ilene Schneider
Could here be a direct connection between metabolism and cancer? Researchers in Texas and Austria seem to think there is.
Disrupted metabolism can cause lymphoma, say researchers.
The team, which included members of the University of Texas Health Science Center departments of medicine and biochemistry, investigators from the UT Southwestern Medical Center at Dallas and a group of collaborators from Austria, has discovered information that directly links disrupted metabolism (energy production in cells) to a common and often fatal type of lymphoma. The group announced its findings in Nature Communications, as reported in Science Daily (http://www.sciencedaily.com/releases/2015/07/150717142435.htm).

According to Medical News Today, lymphoma, a form of cancer that affects the immune system, can occur at any age. It is the most common cancer in young people. Lymphoma is a cancer of immune cells called lymphocytes, a type of white blood cell. There are two broad types of lymphoma -- Hodgkin's and non-Hodgkin's -- and many subtypes. Lymphoma is often very treatable, and most people live for a long time after being diagnosed
(http://www.medicalnewstoday.com/articles/146136.php)

"The link between metabolism and cancer has been proposed or inferred to exist for a long time, but what is more scarce is evidence for a direct connection -- genetic mutations in metabolic enzymes," explains senior author Ricardo C.T. Aguiar, M.D., Ph.D., associate professor of hematology-oncology in the School of Medicine and a faculty scientist with the Cancer Therapy & Research Center (CTRC) at the UT Health Science Center and the South Texas Veterans Health Care System, Audie L. Murphy Division. "We have discovered a metabolic imbalance that is oncogenic or pro-cancer."

The team discovered that the gene that codes the enzyme D2-hydroxyglutarate dehydrogenase (D2HGDH) is "mutated in a subset of cancers called diffuse large B-cell lymphomas," the Science Daily article says. "The mutated lymphoma cell displays a deficiency of a metabolite called alpha-ketoglutarate (?-KG), which is needed in steady levels for cells to be healthy."

According to Dr. Aguiar, "When the levels of ?-KG are abnormally low, another class of enzymes called dioxygenases don't function properly, resulting in a host of additional disturbances. Because ?-KG has been recently identified as a critical regulator of aging and stem cell maintenance, the implications of our findings are broad and not limited to cancer biology."
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAR 11, 2021
Cancer
Placenta structure resembles that of tumors
MAR 11, 2021
Placenta structure resembles that of tumors
Research published yesterday in the journal Nature provides further insight into how the placenta differs from other hum ...
APR 10, 2021
Cancer
Administration of this immune-stimulating drug pre-surgery could help pancreatic cancer patients
APR 10, 2021
Administration of this immune-stimulating drug pre-surgery could help pancreatic cancer patients
New findings support the administration of a CD40 immune-stimulating drug to early-stage pancreatic cancer patients in a ...
MAY 04, 2021
Clinical & Molecular DX
Vibrating Needles Make for Better Biopsies
MAY 04, 2021
Vibrating Needles Make for Better Biopsies
  To understand what’s going on with a patient, doctors may take a biopsy—a sample of tissue extracted ...
MAY 20, 2021
Cancer
High red meat consumption and low education level associated with early-onset colorectal cancer
MAY 20, 2021
High red meat consumption and low education level associated with early-onset colorectal cancer
Research published recently in JNCI Cancer Spectrum reports that higher red meat and alcohol consumption, as well as low ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
Loading Comments...